Press Releases

Date Title  
Toggle Summary West Appoints Kimberly Banks MacKay as Senior Vice President General Counsel and Corporate Secretary
EXTON, Pa. , Nov. 9, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate Secretary,
West Appoints Kimberly Banks MacKay as Senior Vice President General Counsel and Corporate Secretary
EXTON, Pa. , Nov. 9, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate Secretary,
Toggle Summary West Announces Increase to Fourth-Quarter 2020 Dividend
EXTON, Pa. , Oct. 28, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per share, a 6.25%
West Announces Increase to Fourth-Quarter 2020 Dividend
EXTON, Pa. , Oct. 28, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per share, a 6.25%
Toggle Summary West Launches New Vial2Bag Advanced™ 20mm Admixture Device
Universal, needle-free admixture device for immediate use IV administration designed to maximize the benefits of point-of-care nursing EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc.  (NYSE: WST), West Pharmaceutical Services, Inc.
West Launches New Vial2Bag Advanced™ 20mm Admixture Device
Universal, needle-free admixture device for immediate use IV administration designed to maximize the benefits of point-of-care nursing EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc.  (NYSE: WST), West Pharmaceutical Services, Inc.
Toggle Summary West Announces Third-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.     Third-Quarter 2020 Summary (comparisons to
West Announces Third-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.     Third-Quarter 2020 Summary (comparisons to
Toggle Summary West to Host Third-Quarter 2020 Conference Call
EXTON, Pa. , Oct. 8, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2020 financial results before the market opens on Thursday, October 22, 2020 ,
West to Host Third-Quarter 2020 Conference Call
EXTON, Pa. , Oct. 8, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2020 financial results before the market opens on Thursday, October 22, 2020 ,
Toggle Summary West Announces Second-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 23, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial guidance.
West Announces Second-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 23, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial guidance.
Toggle Summary West Announces Third-Quarter 2020 Dividend
EXTON, Pa. , July 15, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.  The dividend
West Announces Third-Quarter 2020 Dividend
EXTON, Pa. , July 15, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.  The dividend
Toggle Summary West to Host Second-Quarter 2020 Conference Call
EXTON, Pa. , July 9, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020 , and
West to Host Second-Quarter 2020 Conference Call
EXTON, Pa. , July 9, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020 , and
Toggle Summary West Pharmaceutical Services, Inc. to Join S&P 500 Index
EXTON, Pa. , May 21, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P ® 500, which will become effective after close of trading today.  "We are honored to be
West Pharmaceutical Services, Inc. to Join S&P 500 Index
EXTON, Pa. , May 21, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P ® 500, which will become effective after close of trading today.  "We are honored to be
Toggle Summary West to Participate in Upcoming Investor Conferences
EXTON, Pa. , May 7, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May 14, 2020 , as well
West to Participate in Upcoming Investor Conferences
EXTON, Pa. , May 7, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May 14, 2020 , as well
Toggle Summary West ’By the Side’ of Communities to Support Global, National and Local COVID-19 Pandemic Efforts
Key donations made to the World Health Organization COVID-19 Solidarity Response Fund, American Red Cross, American Nurses Foundation, No Kid Hungry and Philabundance Exton, PA — April 28, 2020 — Building on a strong culture of giving back to the communities where team members live and work, West
West ’By the Side’ of Communities to Support Global, National and Local COVID-19 Pandemic Efforts
Key donations made to the World Health Organization COVID-19 Solidarity Response Fund, American Red Cross, American Nurses Foundation, No Kid Hungry and Philabundance Exton, PA — April 28, 2020 — Building on a strong culture of giving back to the communities where team members live and work, West
Toggle Summary West Announces First-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.
West Announces First-Quarter 2020 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.
Toggle Summary West to Host Virtual Shareholders Meeting
EXTON, Pa. , April 20, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19
West to Host Virtual Shareholders Meeting
EXTON, Pa. , April 20, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19
Toggle Summary West to Host First-Quarter 2020 Conference Call
EXTON, Pa. , April 9, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2020 financial results before the market opens on Thursday, April 23, 2020 ,
West to Host First-Quarter 2020 Conference Call
EXTON, Pa. , April 9, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2020 financial results before the market opens on Thursday, April 23, 2020 ,
Toggle Summary West Announces Second-Quarter Dividend
EXTON, Pa. , Feb. 25, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share.
West Announces Second-Quarter Dividend
EXTON, Pa. , Feb. 25, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share.
Toggle Summary West Elects New Director to the Board
EXTON, Pa. , Feb. 17, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr.
West Elects New Director to the Board
EXTON, Pa. , Feb. 17, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr.
Toggle Summary West Announces Fourth-Quarter and Full-Year 2019 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.
West Announces Fourth-Quarter and Full-Year 2019 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.
Toggle Summary West Launches New Product Innovations at Pharmapack 2020
AccelTRA® Component Line Extensions, New Container Closure System and Ready Pack™ System Featuring SCHOTT iQ® Platform Bring Greater Value to Global Customers, Advance West Industry Leadership EXTON, Pa. , Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc.
West Launches New Product Innovations at Pharmapack 2020
AccelTRA® Component Line Extensions, New Container Closure System and Ready Pack™ System Featuring SCHOTT iQ® Platform Bring Greater Value to Global Customers, Advance West Industry Leadership EXTON, Pa. , Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc.
Toggle Summary West to Host Fourth-Quarter and Full-Year 2019 Conference Call
EXTON, Pa. , Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on Thursday,
West to Host Fourth-Quarter and Full-Year 2019 Conference Call
EXTON, Pa. , Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on Thursday,
Toggle Summary West Recognized as a Top Company for Corporate Responsibility
EXTON, Pa. , Jan. 28, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Business Daily .
West Recognized as a Top Company for Corporate Responsibility
EXTON, Pa. , Jan. 28, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Business Daily .
Toggle Summary West Announces First-Quarter Dividend, Share Repurchase Program and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.
West Announces First-Quarter Dividend, Share Repurchase Program and Participation in Upcoming Investor Conference
EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.
Toggle Summary West Announces Participation in Upcoming Investor Conference
EXTON, Pa. , Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in
West Announces Participation in Upcoming Investor Conference
EXTON, Pa. , Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in
Toggle Summary West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System
Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ --  (Booths #F62 & #F10 -Hall 11.1 )   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the
West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System
Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ --  (Booths #F62 & #F10 -Hall 11.1 )   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the
Toggle Summary West Launches Two New Elastomer Product Innovations at CPhI Worldwide
Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company's Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc.
West Launches Two New Elastomer Product Innovations at CPhI Worldwide
Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company's Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc.
Toggle Summary West Announces Third-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.
West Announces Third-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices
Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ --  (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
West Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices
Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ --  (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today
Toggle Summary West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery
EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.
West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery
EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.
Toggle Summary West to Host Third-Quarter 2019 Conference Call
  EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019 ,
West to Host Third-Quarter 2019 Conference Call
  EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019 ,
Toggle Summary West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September.
West Announces Participation in Upcoming September Investor Conferences
EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September.
Toggle Summary West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.
West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West to Host Second-Quarter 2019 Conference Call
EXTON, Pa., July 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019 ,
West to Host Second-Quarter 2019 Conference Call
EXTON, Pa., July 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019 ,
Toggle Summary West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
Company Announces New AccelTRA® Component Program Product Extension, Showcases Industry Thought Leadership at Conference EXTON, Pa. , May 22, 2019 /PRNewswire/ --  West Pharmaceutical Services , Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards
Company Announces New AccelTRA® Component Program Product Extension, Showcases Industry Thought Leadership at Conference EXTON, Pa. , May 22, 2019 /PRNewswire/ --  West Pharmaceutical Services , Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is
Toggle Summary West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.
Toggle Summary West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
West Announces First-Quarter 2019 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.
Toggle Summary West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
West Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree
EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.
Toggle Summary West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
West to Host First-Quarter 2019 Conference Call
EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,
Toggle Summary West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
West Expands Presence in Korea with New Sales Office
SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West
Toggle Summary West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
West Opens New Digital Technology Center in Bengaluru, India
BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and
Toggle Summary West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
West Announces Quarterly Dividend and Share Repurchase Program
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019
Toggle Summary West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary
West Announces Fourth-Quarter and Full-Year 2018 Results
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary